Organization | International Medical Center of Japan

International Medical Center of Japan Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial

2005

NCT00280969

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2007

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (6)

abacavir (ziagen) (1 trial)

atazanavir (reyataz) (2 trials)

emtricitabine (emtriva) (1 trial)

lamivudine (epivir) (1 trial)

ritonavir (Norvir) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Phase 3 Trials (1)

efavirenz (sustiva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 3)

Infections (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 7